JOINT Corp
Business
The Joint Corp is a franchisor and operator of chiropractic clinics using a private-pay, non-insurance, cash-based model. The company operates or franchises clinics across multiple states, delivering millions of patient visits annually through a network of franchised and company-owned locations. The Joint offers affordable, appointment-free chiropractic adjustments at prices substantially below industry average, targeting routine wellness and non-acute care. The company is transitioning to a pure-play franchisor, divesting company-owned clinics while expanding through direct franchise sales and a regional developer network.
Summary from 10-K filed 2026-03-13
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenues | 55 | 52 | 47 | 101 | 81 | |
| Total cost of revenues | 11 | 12 | 10 | 9 | 9 | |
| Selling and marketing expenses | 13 | 11 | 9 | 14 | 11 | |
| Depreciation and amortization | 2 | 1 | 1 | 7 | 6 | |
| General and administrative expenses | 30 | 30 | 26 | 70 | 49 | |
| Total selling, general and administrative expenses | 45 | 42 | 36 | 91 | 67 | |
| Net loss on disposition or impairment | 7,898 | 66,019 | −20,894 | 410,215 | 26,789 | |
| Loss from continuing operations | −913,376 | −2 | 318,299 | 828,254 | 5 | |
| Other income, net | 683,872 | 280,287 | 64,293 | −133,101 | −69,878 | |
| Loss from continuing operations before income tax expense | −229,504 | −2 | 254,006 | 695,153 | 5 | |
| Income tax expense | 38,653 | 5,606 | 11 | 68,448 | −1 | |
| Net loss from continuing operations | −268,157 | −2 | −11 | — | — | |
| Income (loss) from discontinued operations before income tax expense | 3 | −4 | 1 | — | — | |
| Income tax expense from discontinued operations | 25,207 | 210,263 | 367,542 | — | — | |
| Net income (loss) from discontinued operations | 3 | −4 | 1 | — | — | |
| Net income (loss) | 3 | −6 | −10 | 626,705 | 7 | |
| Basic (in dollars per share) | −0.02 | −0.11 | −0.73 | — | — | |
| Diluted (in dollars per share) | −0.02 | −0.11 | −0.72 | — | — | |
| Basic (in dollars per share) | 0.21 | −0.28 | 0.07 | — | — | |
| Diluted (in dollars per share) | 0.21 | −0.28 | 0.07 | — | — | |
| Net income (loss) per common share, basic (in dollars per share) | 0.19 | −0.39 | −0.66 | 0.04 | 0.46 | |
| Net income (loss) per common share, diluted (in dollars per share) | 0.19 | −0.38 | −0.65 | 0.04 | 0.44 | |
| Basic weighted average shares outstanding (in shares) | 15 | 15 | 15 | 14 | 14 | |
| Diluted weighted average shares outstanding (in shares) | 15 | 15 | 15 | 15 | 15 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 24 | 25 | 18 | 10 | 20 | |
| Restricted cash | 700,058 | 945,081 | 1 | 805,351 | 386,219 | |
| Accounts receivable, net | 3 | 3 | 3 | 2 | 4 | |
| Deferred franchise and regional development costs, current portion | 945,933 | 1 | 1 | 1 | 994,587 | |
| Prepaid expenses and other current assets | 2 | 2 | 2 | 2 | 2 | |
| Discontinued operations current assets ($1.0 million and $1.1 million attributable to VIEs, respectively) | 22 | 43 | 20 | — | — | |
| Total current assets | 52 | 75 | 44 | 18 | 27 | |
| Property and equipment, net | 3 | 3 | 4 | — | — | |
| Operating lease right-of-use asset | 2 | 555,536 | 466,268 | 21 | 18 | |
| Deferred franchise and regional development costs, net of current portion | 4 | 5 | 5 | 6 | 6 | |
| Deposits and other assets | 319,460 | 300,779 | 254,299 | 756,386 | 567,202 | |
| Total assets | 61 | 83 | 87 | 93 | 85 | |
| Accounts payable | 2 | 2 | 1 | 3 | 2 | |
| Accrued expenses | 2 | 2 | 1 | 1 | 2 | |
| Co-op funds liability | 700,058 | 945,082 | 1 | 805,351 | 386,219 | |
| Payroll liabilities | 4 | 4 | 858,862 | 2 | 4 | |
| Operating lease liability, current portion | 194,179 | 483,337 | 412,601 | 5 | 5 | |
| Deferred franchise fee revenue, current portion | 3 | 3 | 3 | 2 | 3 | |
| Upfront regional developer fees, current portion | 277,394 | 288,095 | 362,326 | 487,250 | — | |
| Other current liabilities | 611,231 | 603,250 | 483,249 | 597,294 | 539,500 | |
| Discontinued operations current liabilities ($6.1 million and $7.1 million attributable to VIEs, respectively) | 21 | 37 | 25 | 0 | — | |
| Total current liabilities | 33 | 49 | 34 | 23 | 21 | |
| Operating lease liability, net of current portion | 2 | 311,689 | 448,308 | 19 | 17 | |
| Deferred franchise fee revenue, net of current portion | 11 | 12 | 14 | 14 | 15 | |
| Upfront regional developer fees, net of current portion | 355,556 | 672,334 | 1 | 2 | — | |
| Total liabilities | 46 | 62 | 62 | 61 | 56 | |
| Commitments and contingencies (Note 10) | — | — | — | — | — | |
| Series A preferred stock, $0.001 par value; 50,000 shares authorized, zero issued and outstanding, respectively | 0 | 0 | 0 | 0 | 0 | |
| Common stock, $0.001 par value; 20,000,000 shares authorized, 15,471,715 shares issued and 14,142,626 shares outstanding and 15,192,893 shares issued and 15,159,878 shares outstanding, respectively | 15,471 | 15,192 | 14,783 | 14,560 | 14,450 | |
| Additional paid-in capital | 52 | 49 | 47 | 46 | 44 | |
| Treasury stock 1,329,089 shares and 33,015 shares, at cost, respectively | −12 | −870,058 | −860,475 | −856,642 | −850,838 | |
| Accumulated deficit | −25 | −28 | −22 | −12 | −14 | |
| Total The Joint Corp. stockholders equity | 15 | 21 | 25 | 33 | 30 | |
| Non-controlling Interest | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | |
| Total equity | 15 | 21 | 25 | 33 | 30 | |
| Total liabilities and stockholders equity | 61 | 83 | 87 | 93 | 85 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 2 | 5 | 9 | 7 | 6 | |
| Net loss on disposition or impairment | 5 | 8 | 3 | — | — | |
| Net franchise fees recognized upon termination of franchise agreements | −347,097 | −239,335 | −217,827 | −68,537 | −133,007 | |
| Deferred income taxes | 93,066 | −55,556 | 11 | −441,353 | — | |
| Provision for credit losses | 286,232 | 220,893 | 0 | — | — | |
| Stock-based compensation expense | 1 | 2 | 2 | 1 | 1 | |
| Accounts receivable | 2 | −2 | 192,348 | −154,672 | −2 | |
| Prepaid expenses and other current assets | −35,389 | 101,167 | −341,478 | 183,406 | −715,740 | |
| Deferred franchise costs | 547,192 | 499,285 | 355,952 | −351,151 | −1 | |
| Deposits and other assets | −5,276 | 8,827 | 1,492 | −189,184 | −148,516 | |
| Accounts payable | −391,127 | 68,258 | −1 | 818,265 | −14,373 | |
| Accrued expenses | −3 | 5 | 793,679 | −1 | 886,738 | |
| Payroll liabilities | −839,892 | 2 | 1 | −2 | 1 | |
| Operating leases | −5 | −4 | −107,735 | — | — | |
| Deferred revenue | −1 | −597,489 | 301,095 | 3 | 4 | |
| Upfront regional developer fees | −285,443 | −421,213 | −598,778 | −1 | — | |
| Other liabilities | −543,663 | −121,408 | 128,647 | 900,151 | 1 | |
| Net cash provided by operating activities | 2 | 9 | 15 | 8 | 15 | |
| Proceeds from sale of clinics | 8 | 554,100 | 0 | 105,200 | 0 | |
| Purchase of property and equipment | −2 | −1 | −5 | −6 | −7 | |
| Net cash provided by (used in) investing activities | 6 | −631,547 | −6 | −18 | −14 | |
| Payments of finance lease obligations | −4,354 | −25,484 | −24,432 | −49,855 | −80,322 | |
| Purchases of treasury stock under employee stock plans | −8,440 | −9,583 | — | — | — | |
| Purchases of common stock under stock repurchase programs | −11 | 0 | −3,833 | −5,804 | −707,727 | |
| Proceeds from exercise of stock options | 2 | 33,708 | 202,386 | 384,269 | 2 | |
| Repayment of Debt under the Credit Agreement | 0 | −2 | 0 | 0 | −3 | |
| Net cash used in financing activities | −10 | −2 | 174,121 | 328,610 | −2 | |
| (Decrease) increase in cash, cash equivalents and restricted cash | −2 | 7 | 9 | −9 | −907,291 | |
| Interest | 50,694 | 69,445 | 173,062 | — | — | |
| Income taxes | 626,752 | 610,492 | 569,765 | — | — | |
| Unpaid purchases of property and equipment | 245,250 | 124,699 | 140,055 | — | — | |
| Stock option exercise receivable | 0 | 896,766 | 0 | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is JOINT Corp's CIK number?
JOINT Corp's SEC CIK number is 0001612630 (1612630). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find JOINT Corp's SEC filings?
All of JOINT Corp's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did JOINT Corp last report earnings?
JOINT Corp (JYNT) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001612630-26-000048). This is JOINT Corp's most recent earnings filing of record — not a forecast of its next earnings date.
What is JOINT Corp's most recent earnings 8-K?
JOINT Corp's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001612630-26-000048. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View JOINT Corp's latest earnings 8-K →
Look up any company's CIK number →